학술논문

Androgen-targeting therapeutics mitigate the adverse effect of GnRH agonist on the risk of neurodegenerative disease in men treated for prostate cancer
Document Type
Article
Source
In: Cancer Medicine. (Cancer Medicine, July 2022, 11(13):2687-2698)
Subject
Language
English
ISSN
20457634